Cargando…
Correlation between serum IGF-1 and EGF levels and neuropsychiatric and cognitive in Parkinson’s disease patients
BACKGROUND: Insulin-like growth factor 1 (IGF-1) and epidermal growth factor (EGF) exert neuroprotective effects in Parkinson’s disease (PD). To date, studies on the relationships between serum IGF-1 and EGF levels and nonmotor symptoms in PD patients have been rare. METHODS: A Siemens automatic che...
Autores principales: | Shi, Xiaoxue, Zheng, Jinhua, Ma, Jianjun, Li, Dongsheng, Gu, Qi, Chen, Siyuan, Wang, Zhidong, Sun, Wenhua, Li, Mingjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925564/ https://www.ncbi.nlm.nih.gov/pubmed/36383265 http://dx.doi.org/10.1007/s10072-022-06490-1 |
Ejemplares similares
-
Plasma arylsulfatase A levels are associated with cognitive function in Parkinson’s disease
por: Li, Mingjian, et al.
Publicado: (2022) -
Correlation of Decreased Serum Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Levels With Non-motor Symptoms in Patients With Parkinson’s Disease
por: Hu, Shiyu, et al.
Publicado: (2021) -
Low serum uric acid levels are associated with the nonmotor symptoms and brain gray matter volume in Parkinson’s disease
por: Shi, Xiaoxue, et al.
Publicado: (2021) -
Increased Plasma Heme Oxygenase-1 Levels in Patients With Early-Stage Parkinson’s Disease
por: Sun, Wenhua, et al.
Publicado: (2021) -
MicroRNA-181a–2–3p shuttled by mesenchymal stem cell-secreted extracellular vesicles inhibits oxidative stress in Parkinson’s disease by inhibiting EGR1 and NOX4
por: Ma, Jianjun, et al.
Publicado: (2022)